To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03696784
Title Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill RECRUITING Chapel Hill North Carolina 27599 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field